---
layout: post
title: USAN Watch - October 2010
date: '2010-10-12T06:52:00.013+01:00'
author: John Overington
tags:
- INNS and USANS
modified_time: '2010-12-23T09:56:45.011Z'
thumbnail: http://2.bp.blogspot.com/_SlPG9DIz_AA/TRMcWytfSnI/AAAAAAAAA9k/OVeIhUYNs6Y/s72-c/inns+and+usans.png
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-6906390274032597912
blogger_orig_url: http://chembl.blogspot.com/2010/10/october-2010-usans-have-just-been.html
---

<div class="separator" style="clear: both; text-align: center;"><a href="http://2.bp.blogspot.com/_SlPG9DIz_AA/TRMcWytfSnI/AAAAAAAAA9k/OVeIhUYNs6Y/s1600/inns+and+usans.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" src="http://2.bp.blogspot.com/_SlPG9DIz_AA/TRMcWytfSnI/AAAAAAAAA9k/OVeIhUYNs6Y/s1600/inns+and+usans.png" /></a></div><div class="separator" style="clear: both; text-align: center;"><br />
</div><br />
<center>  </center>    <br />
The October 2010 USANs have just been published, these are:<br />
<br />
<center><table border="1"><tbody>
<tr><td><b>USAN</b></td><td><b>Research code</b> </td><td><b>Drug Type</b> </td><td><b>Drug Class</b></td><td><b>Target</b> </td></tr>
<tr><td>bedaquiline</td><td>TMC-207, R-207910</td><td>small molecule</td><td>therapeutic</td><td>ATP synthase</td></tr>
<tr><td>bedaquiline fumarate</td><td>TMC-207, R-403323</td><td>small molecule</td><td>therapeutic</td><td>ATP synthase</td></tr>
<tr><td>edivoxetine hydrochloride</td><td>LY-2216684</td><td>small molecule</td><td>therapeutic</td><td>NET</td></tr>
<tr><td>eteplirsen</td><td>AVI-4658</td><td>oligonucleotide</td><td>therapeutic</td><td></td></tr>
<tr><td>latrepirdine dihydrochloride</td><td>dimebolin, Dimebon</td><td>small molecule</td><td>therapeutic</td><td>complex (inc. NMDAr, AMPAr, L-type Ca channel, alpha receptors, 5HT2C, 5HT5A, 5HT6, H1 H2)</td></tr>
<tr><td>lenvatinib</td><td>ER-203492, E-7080</td><td>small molecule</td><td>therapeutic</td><td>VEGFR2</td></tr>
<tr><td>naronapride</td><td>ATI-7505</td><td>small molecule</td><td>therapeutic</td><td>5HT4R</td></tr>
<tr><td>naronapride dihydrohloride</td><td>ATI-7505</td><td>small molecule</td><td>therapeutic</td><td>5HT4R</td></tr>
<tr><td>onartuzumab</td><td>PRO143966, MetMAb</td><td>mAb</td><td>therapeutic</td><td>Scatter Factor receptor</td></tr>
<tr><td>ornithine phenylacetate</td><td>OCR-002, L-OP, OP</td><td>small molecule</td><td>therapeutic</td><td>n/a</td></tr>
<tr><td>peginesatide acetate</td><td>AF-37702</td><td>peptide</td><td>therapeutic</td><td>EPOr</td></tr>
<tr><td>pomaglumated methionil</td><td>LY-2140023</td><td>small molecule</td><td>therapeutic</td><td>mGluR2/3</td></tr>
<tr><td>secukinumab</td><td>AIN-457</td><td>mAb</td><td>therapeutic</td><td>IL-17A</td></tr>
<tr><td>semaglutide</td><td>NNC-0113-0217</td><td>peptide</td><td>therapeutic</td><td>GLP1R</td></tr>
</tbody><tbody> </tbody></table></center><center style="text-align: left;"><br />
</center><center style="text-align: left;">There are 10 distinct drug structures here (some are parent and salt pairs), six are synthetic small molecules, largely from established target classes, and four are biological drugs. Latrepirdine a.k.a.&nbsp;<a href="http://en.wikipedia.org/wiki/Dimebon">Dimebon</a> is a molecule showing broad pharmacology, and a rollercoaster ride through licensing and development.</center>